I recently ran a poll on my blog about how the FDA is doing on handling stem cell clinics.
There is substantial debate in the stem cell arena about how the FDA handles stem cell clinics ranging from the view that the agency is far too strict to excessively lenient.
The results of the poll reflect a great deal of dissatisfaction with the job that the FDA is doing on stem cell clinics.
Only 9% of respondents felt that the FDA is currently do things just about right.
While the top 2 answers were polar extremes, by a large margin the top answer was that the FDA was much too lenient.
Although Internet polls of this kind are not scientific, they can reflect sentiments of a community.